Clinical Trial Update: Nab-Paclitaxel, Cisplatin, and Cetuximab With Concurrent Radiation Therapy for Locally Advanced Head and Neck Cancer [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 trial evaluating nab-paclitaxel, cisplatin, and cetuximab with concurrent radiation therapy for locally advanced head and neck cancer has completed wi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Head and Neck Cancer

Drugs mentioned

• CISPLATIN (cisplatin)
• Cetuximab (cetuximab)
• Nab-paclitaxel (paclitaxel protein-bound)
• Radiation therapy

Snippet

Sponsor: University of Texas Southwestern Medical Center | Conditions: Head and Neck Cancer | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2018-08-08